Françoise Mézin

793 total citations
10 papers, 664 citations indexed

About

Françoise Mézin is a scholar working on Immunology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Françoise Mézin has authored 10 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Rheumatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Françoise Mézin's work include Immune Response and Inflammation (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Françoise Mézin is often cited by papers focused on Immune Response and Inflammation (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Françoise Mézin collaborates with scholars based in Switzerland, United States and France. Françoise Mézin's co-authors include Cem Gabay, Gaby Palmer, Dominique Talabot‐Ayer, Olivier Donzé, David Moulin, Pierre‐André Guerne, David Magne, Stéphane Genevay, Enrico Tessitore and Axel Finckh and has published in prestigious journals such as The Journal of Immunology, Spine and Journal of Cellular Physiology.

In The Last Decade

Françoise Mézin

10 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Françoise Mézin Switzerland 9 368 201 138 104 104 10 664
Katia Giuliodori Italy 17 283 0.8× 92 0.5× 82 0.6× 96 0.9× 65 0.6× 38 756
Martina S. Elias United Kingdom 9 192 0.5× 163 0.8× 194 1.4× 95 0.9× 20 0.2× 11 580
Ira D. Lawrence United States 13 260 0.7× 66 0.3× 140 1.0× 80 0.8× 62 0.6× 19 880
A Tulli Italy 15 150 0.4× 75 0.4× 107 0.8× 68 0.7× 124 1.2× 37 544
Greta Pacini Italy 11 173 0.5× 52 0.3× 199 1.4× 190 1.8× 105 1.0× 24 635
María Victoria Legorreta-Haquet Mexico 14 361 1.0× 108 0.5× 106 0.8× 167 1.6× 35 0.3× 26 704
Richard P. Phipps United States 12 264 0.7× 38 0.2× 36 0.3× 207 2.0× 54 0.5× 12 689
H.-Y. Kim South Korea 11 240 0.7× 56 0.3× 230 1.7× 165 1.6× 47 0.5× 23 676
B. Stott United Kingdom 8 144 0.4× 45 0.2× 167 1.2× 76 0.7× 23 0.2× 13 461
K Shichikawa Japan 17 178 0.5× 376 1.9× 467 3.4× 71 0.7× 393 3.8× 47 1.1k

Countries citing papers authored by Françoise Mézin

Since Specialization
Citations

This map shows the geographic impact of Françoise Mézin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Mézin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Mézin more than expected).

Fields of papers citing papers by Françoise Mézin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Mézin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Mézin. The network helps show where Françoise Mézin may publish in the future.

Co-authorship network of co-authors of Françoise Mézin

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Mézin. A scholar is included among the top collaborators of Françoise Mézin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Mézin. Françoise Mézin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Genevay, Stéphane, Axel Finckh, Françoise Mézin, Enrico Tessitore, & Pierre‐André Guerne. (2009). Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Research & Therapy. 11(6). R169–R169. 36 indexed citations
2.
Genevay, Stéphane, Axel Finckh, Michael Payer, et al.. (2008). Elevated Levels of Tumor Necrosis Factor-Alpha in Periradicular Fat Tissue in Patients With Radiculopathy From Herniated Disc. Spine. 33(19). 2041–2046. 75 indexed citations
3.
Moulin, David, Olivier Donzé, Dominique Talabot‐Ayer, et al.. (2007). Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine. 40(3). 216–225. 265 indexed citations
4.
Magne, David, Françoise Mézin, Gaby Palmer, & P A Guerne. (2006). The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1β and TNF-α. Inflammation Research. 55(11). 469–475. 8 indexed citations
5.
Magne, David, Gaby Palmer, Jenny L. Barton, et al.. (2006). The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Research & Therapy. 8(3). R80–R80. 112 indexed citations
6.
7.
Palmer, Gaby, Danielle Burger, Françoise Mézin, et al.. (2004). The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes. Arthritis Research & Therapy. 6(3). R181–9. 17 indexed citations
8.
Palmer, Gaby, Pierre‐André Guerne, Françoise Mézin, et al.. (2002). Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Research & Therapy. 4(3). 226–31. 38 indexed citations
9.
10.
Relić, Biserka, Jérôme Guicheux, Françoise Mézin, et al.. (2001). IL-4 and IL-13, But Not IL-10, Protect Human Synoviocytes from Apoptosis. The Journal of Immunology. 166(4). 2775–2782. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Giuliodori Breakdown of academic impact, for papers by Martina S. Elias Breakdown of academic impact, for papers by Ira D. Lawrence Breakdown of academic impact, for papers by A Tulli Breakdown of academic impact, for papers by Greta Pacini Breakdown of academic impact, for papers by María Victoria Legorreta-Haquet Breakdown of academic impact, for papers by Richard P. Phipps Breakdown of academic impact, for papers by H.-Y. Kim Breakdown of academic impact, for papers by B. Stott Breakdown of academic impact, for papers by K Shichikawa
Rankless by CCL
2026